Coagulation factor V is a high molecular weight plasma glycoprotein that participates as a cofactor in the conversion of prothrombin to thrombin by factor X.. A phage Agtll Hep G2 cell cDNA expression library was screened by using an affinity-purifiled antibody to human factor V, and 11 positive clones were isolated and plaque-purified. The clone containing the largest cDNA insert contained 2970 nucleotides and coded for 938 amino acids, a stop codon, and 155 nucleotides of 3' noncoding sequence including a poly(A) tail. The coding region includes 651 amino acids from the carboxyl terminus that constitute the light chain of human factor V. and 287 amino acids that are part of the connecting region of the protein. The predicted amino acid sequence agreed completely with 147 amino acid residues that were identified by Edman degradation of cyanogen bromide peptides isolated from the light chain. During the activation of factor V, several peptide bonds are cleaved by thrombin, giving rise to a heavy chain, a connecting fragment(s), and a light chain. The light chain is generated by the cleavage of an Arg-Ser peptide bond. The amino acid sequence of the light chain is homologous (40%) with the carboxyl-terminal fragment (Mr, 73,000) of human factor VIII. Both fragments have a similar domain structure that includes a single ceruloplasmin-related domain followed by two C domains. The carboxyl terminus of the connecting region, however, shows no significant amino acid sequence homology with factor VIII. It is very acidic and contains a number of potential N-linked glycosylation sites. It also contains about 20 tandem repeats of nine amino acids.
Human coagulation factor V is a high molecular weight plasma glycoprotein that is required for rapid thrombin formation and normal hemostasis (1) . It circulates in blood as a large single polypeptide chain (Mr, 330,000) with little or no coagulant activity (2) (3) (4) (5) (6) . During the blood coagulation process, factor V is converted to factor Va by thrombin by limited proteolysis (2) (3) (4) (5) (6) . This makes available binding sites for factor Xa (7) and prothrombin (8) . Factor Va is composed of a heavy chain (Mr, 110,000) and a light chain (Mr, 76,000), and these two chains are held together by calcium ions (3, 6) .
The remainder of the original factor V molecule is released as a large connecting fragment(s) that is rich in carbohydrate (3, 6, 9) . Factor Va binds to cell surfaces (9) (10) (11) (12) and negatively charged phospholipid surfaces (13) (14) (15) (16) through the light chain, and this increases the rate of prothrombin activation -z10,000-fold by factor Xa (17) . Factor Va is readily inactivated by activated protein C (18) , and this results in the cleavage of the heavy chain into two smaller fragments (19) . In addition to its role in prothrombin activation, human factor Va stimulates the activation of protein C by thrombin on phospholipid and cell surfaces (12, 20, 21) . Only the light chain is necessary for this reaction (22) .
Factor V has a number of physical and biological properties that are similar to factor VIII. For instance, factor VIII is also converted to an activated form (factor VIIIa) by thrombin, and this molecule enhances the rate of activation of factor X by factor IXa. This cofactor effect of factor VIIIa is analogous to that of factor Va on the activation of prothrombin. Fass et al. (23) have also reported amino acid sequence homology between the N-terminal portions of the heavy and light chains of bovine factor Va and the corresponding peptides from porcine factor VIIIa. In addition, these sequences showed amino acid sequence homology with ceruloplasmin, a plasma copper-binding protein (24) . Subsequently, both bovine and human factor V have been shown to contain one copper ion per molecule (25) . The complete amino acid sequence of human factor VIII has been determined by cDNA cloning (26, 27) . It contains a triplicated A domain (=350 amino acids) with =30% internal amino acid homology. These A domains are also =30% homologous with the triplicated domains of ceruloplasmin (28) . In contrast to ceruloplasmin, factor VIII also contains a connecting peptide (=900 amino acids) located between the second and third A domains and contains two C domains (=150 amino acids) located near the carboxyl-terminal end of the molecule.
The biosynthesis of factor V has been demonstrated in human Hep G2 cells (29) , bovine aortic endothelial cells (30) , and guinea pig megakaryocytes (31) . In this manuscript, we report the isolation of a cDNA clone from a Hep G2 cDNA library that codes for the carboxyl-terminal 938 amino acids of human factor V. This includes the entire light chain of factor Va (651 amino acids) and a portion of the connecting region (287 amino acids).
MATERIALS AND METHODS
Screening of the Xgtll cDNA Library. Human factor V was prepared by the method of Kane and Majerus (4) , and rabbit antibodies were prepared and affinity-purified by the method of Canfield and Kisiel (32) . The Hep G2 Xgtll cDNA expression library was kindly provided by Frederick S. Hagen (33) . The affinity-purified antibody to human factor V was labeled with 1251I and then used to screen filter blots as described by Young and Davis (34) . Positive clones were also hybridized with a 2P-labeled oligonucleotide probe with a sequence of ACCCAYTCYTGYTCRTACAT, where Y is T or C and R is G or A (35) . This oligonucleotide was synthesized by using an Applied Biosystems (Foster City, CA) oligonucleotide synthesizer.
DNA Sequence Analysis. Phage DNA was prepared from positive clones (36, 37) . The cDNA inserts were isolated after EcoRI digestion. The inserts were then subcloned into pUC9 (38) , followed by subcloning of appropriate restriction fragments into M13 phage cloning vectors mpl8 and mpl9. DNA sequencing was performed by the BAL-31 exonuclease method (39 ers as described (39) . DNA sequences were stored and analyzed on an Apple Macintosh computer using the DNA INSPECTOR program (Textco, West Lebanon, VT) (40) .
Protein Sequence Analysis. The light chain of factor Va was isolated from 10 mg of human factor V after incubation with the factor V activator from Russell's viper venom (6). The light chain was then reduced, carboxymethylated (41) , and digested with cyanogen bromide (42) . The cyanogen bromide peptides were purified by gel filtration on Sephadex G-50 followed by HPLC using an Altex Ultrapore C3 reverse-phase separation column as described by McMullen and Fujikawa (41) . Seven peptides were isolated in sufficient yield to allow automated amino acid sequence analysis with a Beckman 890C sequencer. Amino acid sequences were analyzed by using the ALIGN computer program of Dayhoff et al. (43) .
RESULTS AND DISCUSSION Affinity-purified antibody to human factor V was radiolabeled with 1251 and used for the screening of -2 x 106 phage from a Xgtll Hep G2 cell cDNA expression library. Eleven positive clones were identified and plaque-purified. The clone containing the largest cDNA insert (XHV2970) also hybridized with ACCCAYTCYTGYTCRTACAT, an oligonucleotide complementary to the DNA that codes for the amino acid sequence of Met-Tyr-Glu-Gln-Glu-Trp-Val. This amino acid sequence is present in the light chain of human factor Va. The cDNA insert was then analyzed by restriction mapping and sequenced two or more times (Fig. 1) . Also, =95% of the sequence was determined on both strands. The cDNA insert contained 2970 nucleotides and coded for 938 amino acids, a stop codon (TAG), and 155 nucleotides of 3' noncoding sequence, including a polyadenylylation signal (AATAAA) and a poly(A) tail (Fig. 2) . The predicted amino acid sequence was in complete agreement with 147 amino acids that were identified by Edman degradation of seven cyanogen bromide peptides. These peptides were isolated and purified from the light chain of factor Va and are overlined in Fig. 2 . These data indicate that the cDNA insert in XHV2970 coded for the carboxyl terminus of the protein, including 651 amino acids that constitute the entire light chain of factor Va (see below) and 287 amino acids that form a portion of the connecting region.
The molecular weight of the light chain of human factor Va was calculated to be 71,500 without carbohydrate. The addition of the three potential N-linked oligosaccharide chains with a molecular weight of =2000 each increases the molecular weight of the glycoprotein to =77,500. This is similar to the values of 74,000-78,000, as determined by NaDodSO4/polyacrylamide gel electrophoresis (4-6). The amino acid sequence of the light chain is 40% homologous with the carboxyl-terminal fragment (Mr, 73,000) of human factor VIII (26, 27) . Both fragments have a similar domain structure, including a single ceruloplasmin-related A domain followed by two C domains. The A domain in the light chain of factor Va is =40% homologous with the third A domain of both human ceruloplasmin and human factor VIII (Fig. 3A) . less sequence homology (30-36%) with the first and second A domains of factor VIII and ceruloplasmin. Also, the A domain of the light chain of factor Va contains only a single pair of cysteine residues, whereas the corresponding domains in human factor VIII and ceruloplasmin contain five and three cysteine residues, respectively.
The location and function of the single copper ion associated with factor V remain unknown. Ceruloplasmin contains six copper ions in three types of binding sites (44) . Mann et al. (25) could pot detect type I (blue, 610-nm absorbance) or type III (310-nm absorbance) binding sites in factor V and concluded that the copper may be bound to a type II binding site. By analogy with the type I copper-binding protein plastocyanin, the ligands for the type I copper-binding site at the carboxyl terminus of ceruloplasmin have been proposed to be His-975, Cys-1021, His-1026, and Met-1031 (45) . Only two of these four residues are conserved in the light chain of factor Va (see Fig. 3A ). This is in contrast to factor VIII, in which all four residues are conserved in the first and third A domains (26, 27) . The carboxyl terminus of ceruloplasmin also contains eight closely clustered histidine residues, which have been suggested to play a role in copper binding (45) . Of these eight histidine residues, only three are conserved in factor V (Fig. 2) , while five are conserved in factor VIII (26) .
The two C domains of human factor V show. 35-50o homology with each other and with the C domains of human factor VIII (Fig. 3B) . As was noted previously in factor VIII (29) , these domains share 20%o homology with the slime mold protein discoidin I (46) . Discoidin I is a tetrameric galactosebinding lectin, which is essential for cell adhesion in Dictyostelium discoideum. It contains the amino acid sequence Arg-Gly-Asp that interacts with a specific cell surface receptor (47) . The Arg-Gly-Asp sequence is not present in the two C domains of factor V or factor VIII. The light chain of factor Va binds to negatively charged phospholipid via electrostatic interactions (14, 16) . Pusey and Nelsestuen (16) found that binding was inhibited by 90% when 12% of the lysine residues were modified by citraconic anhydride. It is notable that the C domains in the light chain offactor Va are basic with a calculated charge at pH 7.0 of + 14 (excluding carbohydrate). There are several clusters of basic residues, including a cluster of four or five arginine and lysine residues at the end of each C domain. In contrast, the A domain of the light chain of factor Va has a calculated charge of -9. A similar charge distribution is seen in the corresponding regions of human factor VIII. It is possible that the binding of the light chain of factor Va to cell and phospholipid surfaces is mediated by the C domains. However, the precise functions of the various domains in factor V must await future experiments.
During the activation of factor V, the light chain is generated by the cleavage of an Arg-Ser bond located between the connecting region and the light chain. Factor V is rapidly activated by thrombin or the factor V activator in Russell's viper venom. The amino acid sequences determined by Edman degradation of the light chain of factor V9 generated by thrombin (D. B. Wilson, personal communication) or the factor V activator in Russell's viper venom ( Biochemistry: Kane and 
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proposed that cleavage of three peptide bonds is required for fragment (287 residues) is very acidic, with a calculated net complete activation of human factor VIII by thrombin. charge of -37 at pH 7.0 (excluding carbohydrate). It is also
The most striking feature of the carboxyl terminus of the rich in proline (12.2%), serine (15.7%), threonine (8.0%), and connecting fragment of factor Va is that it contains at least 20 leucine (15.2%). It is apparently heavily glycosylated because repeats of a sequence of nine amino acids (Fig. 4) . The In the present investigation, =40% of the amino acid sequence of factor V has been established. These findings confirm that factor V, factor VIII, and ceruloplasmin comprise a family of related proteins that have arisen through gene duplication of the A domain (23, 24) . Additional cDNA clones must be obtained to determine the domain structure of the remaining 60% of the factor V molecule and the structural features that give rise to its cofactor activity. 
